We are live on ! Find out more
MIM

Monashee Investment Management Portfolio holdings

AUM $184M
1-Year Est. Return 197.43%
This Fund
S&P 500
This Quarter Est. Return
-5.98%
1 Year Est. Return
+197.43%
3 Year Est. Return
+447.04%
5 Year Est. Return
+479.31%
10 Year Est. Return
+5,610.42%
AUM
$345M
AUM Growth
-$59.3M
Cap. Flow
-$22.6M
Cap. Flow %
-6.55%
Top 10 Hldgs %
88.57%
Holding
63
New
19
Increased
2
Reduced
15
Closed
26

Top Buys

Rank Stock Value
1
VTI icon
Vanguard Morningstar Total Stock Market ETF
VTI
+$26.9M
2
ANTX icon
AN2 Therapeutics
ANTX
+$6.57M
3
SEDG icon
SolarEdge
SEDG
+$5.49M
4
SWX icon
Southwest Gas
SWX
+$5.25M
5
TVTX icon
Travere Therapeutics
TVTX
+$2.66M

Top Sells

Rank Stock Value
1
ADC icon
Agree Realty
ADC
+$8.92M
2
FHTX icon
Foghorn Therapeutics
FHTX
+$5.49M
3
NTRA icon
Natera
NTRA
+$5.14M
4
SOFI icon
SoFi Technologies
SOFI
+$4.74M
5
UP icon
Wheels Up
UP
+$4.28M

Sector Composition

Rank Sector Weight
1 Healthcare 16.01%
2 Utilities 2.9%
3 Technology 1.92%
4 Materials 1.65%
5 Communication Services 0.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VTI icon
1
Vanguard Morningstar Total Stock Market ETF
VTI
$646B
$259M 75.03%
1,137,100
+119,400
+12% +$26.9M
ANTX icon
2
AN2 Therapeutics
ANTX
$181M
$6.53M 1.89%
+433,330
New +$6.57M
SEDG icon
3
SolarEdge
SEDG
$2.37B
$6.45M 1.87%
+20,000
New +$5.49M
HYPR icon
4
Hyperfine
HYPR
$88.4M
$6.21M 1.8%
1,755,038
-416,357
-19% -$1.72M
SWX icon
5
Southwest Gas
SWX
$6.64B
$5.87M 1.7%
+75,000
New +$5.25M
FULC icon
6
Fulcrum Therapeutics
FULC
$241M
$5.6M 1.62%
236,991
-36,054
-13% -$510K
CRBU icon
7
Caribou Biosciences
CRBU
$146M
$4.32M 1.25%
470,000
-34,377
-7% -$362K
SLGC
8
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
$4.09M 1.18%
510,000
-320,000
-39% -$2.82M
KALV
9
DELISTED
KalVista Pharmaceuticals
KALV
$3.89M 1.13%
264,111
-35,889
-12% -$516K
DCGO icon
10
DocGo
DCGO
$64.2M
$3.79M 1.1%
409,431
-340,569
-45% -$2.56M
MYPS icon
11
PLAYSTUDIOS Inc
MYPS
$76.2M
$3.39M 0.98%
699,503
-300,497
-30% -$1.33M
PLL
12
DELISTED
Piedmont Lithium
PLL
$2.92M 0.85%
+40,000
New +$2.25M
LFG
13
DELISTED
Archaea Energy Inc.
LFG
$2.85M 0.83%
+130,000
New +$2.36M
VIEW
14
DELISTED
View, Inc. Class A Common Stock
VIEW
$2.76M 0.8%
25,000
– –
DYN icon
15
Dyne Therapeutics
DYN
$4.68B
$2.7M 0.78%
279,704
+184,404
+193% +$1.57M
TVTX icon
16
Travere Therapeutics
TVTX
$5.17B
$2.58M 0.75%
+100,000
New +$2.66M
NARI
17
DELISTED
Inari Medical, Inc. Common Stock
NARI
$2.27M 0.66%
+25,000
New +$2.05M
ACI icon
18
Albertsons Companies
ACI
$5.85B
$2M 0.58%
+60,000
New +$1.87M
CLYM
19
Climb Bio
CLYM
$693M
$1.91M 0.55%
227,201
-72,799
-24% -$679K
HESM icon
20
Hess Midstream
HESM
$5.19B
$1.8M 0.52%
+60,000
New +$1.81M
CMPX icon
21
Compass Therapeutics
CMPX
$349M
$1.74M 0.5%
1,270,211
-729,789
-36% -$1.51M
KDNY
22
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$1.47M 0.43%
90,000
-5,000
-5% -$68K
LONA
23
LeonaBio Inc
LONA
$66.1M
$1.35M 0.39%
+10,000
New +$1.05M
NWN icon
24
Northwest Natural Holdings
NWN
$2.15B
$1.29M 0.37%
+25,000
New +$1.25M
APLS
25
DELISTED
Apellis Pharmaceuticals
APLS
$1.25M 0.36%
+24,555
New +$1.08M
1
2 3

Similar funds

EFIC
Eliot Finkel Investment Counsel Beverly Hills, California $184M AUM 33.43% 1-Year Est. Return
SWMG
Sard Wealth Management Group Atlanta, Georgia $184M AUM 11.26% 1-Year Est. Return
AAM
Ameraudi Asset Management New York $184M AUM 15.4% 1-Year Est. Return
IFPL
Investments & Financial Planning LLC Lexington, Kentucky $184M AUM 17.7% 1-Year Est. Return
RFG
RFP Financial Group Atlanta, Georgia $184M AUM 16.06% 1-Year Est. Return
KWM
KMT Wealth Management El Segundo, California $184M AUM 17.2% 1-Year Est. Return
NAM
Nutshell Asset Management Sevenoaks, United Kingdom $184M AUM 2.02% 1-Year Est. Return
GCGM
General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return

Monashee Investment Management's Q1 2022 Portfolio in Review

As of Q1 2022, Monashee Investment Management held 63 positions worth $345M, down 15% from $405M the previous quarter. Its ten largest holdings account for 89% of the portfolio.

Monashee Investment Management withdrew a net $22.6M in Q1 2022, closing 26 positions and reducing 15 holdings. Its most notable exit was Agree Realty, an estimated $8.92M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 24% a quarter earlier, followed by Utilities and Technology.

Against the trend, Monashee Investment Management opened a new position in AN2 Therapeutics worth $6.53M.

  • Monashee Investment Management's largest Q1 2022 buy was AN2 Therapeutics: 433,330 shares worth $6.53M.
  • Monashee Investment Management added most to Vanguard Morningstar Total Stock Market ETF in Q1 2022, an estimated $26.9M increase.
  • Monashee Investment Management's biggest Q1 2022 reduction was Pardes Biosciences, Inc. Common Stock, cutting an estimated $3.36M.
  • Monashee Investment Management fully exited Agree Realty in Q1 2022, selling an estimated $8.92M.
  • Monashee Investment Management's ten largest holdings make up 89% of its $345M portfolio in Q1 2022.
  • Monashee Investment Management opened 19 new positions and closed 26 in Q1 2022.
  • Monashee Investment Management's portfolio value fell 15% quarter-over-quarter to $345M.

Based on Monashee Investment Management's 13F filing for Q1 2022, filed 12 May 2022.